Lakeland Industries (LAKE) Expected to Announce Earnings on Wednesday

Lakeland Industries (NASDAQ:LAKEGet Free Report) is projected to announce its Q4 2026 results after the market closes on Wednesday, April 8th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $49.6690 million for the quarter. Individuals may visit the the company’s upcoming Q4 2026 earning summary page for the latest details on the call scheduled for Thursday, April 16, 2026 at 4:00 PM ET.

Lakeland Industries Price Performance

Lakeland Industries stock opened at $8.47 on Monday. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.83 and a quick ratio of 1.48. Lakeland Industries has a fifty-two week low of $7.15 and a fifty-two week high of $20.50. The firm has a fifty day moving average price of $8.96 and a two-hundred day moving average price of $11.69. The firm has a market cap of $83.09 million, a price-to-earnings ratio of -1.93 and a beta of 1.34.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Wall Street Zen lowered Lakeland Industries from a “hold” rating to a “strong sell” rating in a research note on Saturday, December 13th. UBS Group set a $14.00 target price on Lakeland Industries in a research note on Wednesday, December 10th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Lakeland Industries in a report on Thursday, January 22nd. DA Davidson reaffirmed a “neutral” rating and issued a $14.00 price target (down from $20.00) on shares of Lakeland Industries in a research report on Wednesday, December 10th. Finally, Zacks Research upgraded Lakeland Industries from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $15.75.

Read Our Latest Research Report on Lakeland Industries

Key Headlines Impacting Lakeland Industries

Here are the key news stories impacting Lakeland Industries this week:

  • Neutral Sentiment: Lake Street Capital cut its price target on LAKE from $19.00 to $16.00 but kept a “buy” rating — a downward revision to expectations but still a constructive view on longer‑term upside. Read More.
  • Negative Sentiment: Pomerantz filed an official class action in the Southern District of New York alleging securities‑law violations for purchases between Dec. 1, 2023 and Dec. 9, 2025 — this formal complaint can lead to discovery, damages exposure and management distraction. Read More.
  • Negative Sentiment: Multiple plaintiff firms (Faruqi & Faruqi, Robbins LLP, Rosen Law, Frank R. Cruz, Kirby McInerney and others) have issued investor notices and are soliciting lead plaintiffs ahead of an April 24, 2026 deadline — a cluster of suits/claims increases the probability of consolidated litigation and potential settlement/defense costs. Read More.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. UBS Group AG lifted its stake in shares of Lakeland Industries by 818.1% in the third quarter. UBS Group AG now owns 62,595 shares of the medical instruments supplier’s stock valued at $926,000 after buying an additional 55,777 shares during the period. Goldman Sachs Group Inc. increased its stake in Lakeland Industries by 42.3% during the first quarter. Goldman Sachs Group Inc. now owns 44,435 shares of the medical instruments supplier’s stock valued at $902,000 after acquiring an additional 13,219 shares during the period. Jane Street Group LLC raised its holdings in Lakeland Industries by 107.7% in the 1st quarter. Jane Street Group LLC now owns 40,180 shares of the medical instruments supplier’s stock valued at $816,000 after acquiring an additional 20,832 shares in the last quarter. Marshall Wace LLP raised its holdings in Lakeland Industries by 419.4% in the 2nd quarter. Marshall Wace LLP now owns 56,700 shares of the medical instruments supplier’s stock valued at $772,000 after acquiring an additional 45,783 shares in the last quarter. Finally, LPL Financial LLC bought a new stake in shares of Lakeland Industries in the 4th quarter worth approximately $406,000. Institutional investors and hedge funds own 71.69% of the company’s stock.

Lakeland Industries Company Profile

(Get Free Report)

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.

Read More

Earnings History for Lakeland Industries (NASDAQ:LAKE)

Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.